Can the premises of the spasm of resistance vessel concept permit improvement in the treatment and prevention of ischemic heart disease?

Medical Hypotheses

Volumn 60, Issue 1, 2003, Pages 36-51

  Hellstrom, H Richard ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE;

ARTICLE; CARDIOVASCULAR RISK; CONCEPT FORMATION; CORONARY ARTERY DISEASE; DISEASE SEVERITY; EMBOLISM; ENZYME INHIBITION; EXERCISE; HEART INFARCTION; HEART PROTECTION; ISCHEMIC HEART DISEASE; MENTAL STRESS; PATHOGENESIS; PRIORITY JOURNAL; REPERFUSION INJURY; SYNDROME X; SYSTOLE; THROMBOCYTE; THROMBOSIS; VARIANT ANGINA PECTORIS; VASOSPASM;

EID: 0037222438     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(02)00330-4     Document Type: Article

References (170)

1. Hellstrom H. R. Vasospasm in ischemic heart disease - A hypothesis. Perspect Biol Med 1973; 16: 427-440.
2. Hellstrom H. R. The spasm of resistance vessel concept of ischemic heart disease and other ischemic diseases. Med Hypotheses 1990; 33: 31-41.
3. Hellstrom H. R. Evidence in support of the spasm of resistance vessel concept of ischemic heart disease: An update in 1993. Med Hypotheses 1993; 41: 11-22.
4. Hellstrom H. R. New evidence for the spasm of resistance vessel concept of ischemic diseases. Med Hypotheses 1999; 53: 200-209.
5. Hellstrom H. R. Occlusions of epicardial arteries might not directly induce symptoms in ischemic heart disease. Med Hypotheses 1999; 53: 533-542.
6. Hellstrom H. R. The altered homeostatic theory: A holistic approach to multiple diseases, including atherosclerosis, ischemic diseases, and hypertension. Med Hypotheses 1999; 53: 194-199.
7. Hellstrom H. R. Can the Premises of the Altered Homeostatic Theory Permit Improvement in the Prevention of Ischemic Heart Disease? In press.
8. Mcfarlane R. G. Haemostasis. In: R. Biggs (ed). Human Blood Coagulation, Haemostasis and Thrombosis. Oxford: Blackwell Scientific Publications, 1976: 608-654.
9. Olsson R. A., Gregg D. E. Myocardial reactive hyperemia in the unanesthetized dog. Am J Physiol 1965; 208: 224-330.
10. Weber K. T., Janicki J. S. The metabolic demand and oxygen supply of the heart: Physiologic and clinical considerations. Am J Cardiol 1979; 44: 722-729.
11. Lesch M., Ross R. S., Braunwald E. Ischemic heart disease. In: G. W. Thorn, R. D. Adams, E. Braunwald, K. J. Isselbacher, R. G. Petersdorf (eds). Harrison's Principles of Internal Medicine. New York: McGraw-Hill, 1977: 1261-1270.
12. Hellstrom H. R. Coronary artery stasis after induced myocardial infarction in the dog. Cardiovasc Res 1971; 5: 371-375.
13. Karmazyn M., Manku M. S., Horrobin D. F. The mechanism of coronary artery spasm: Roles of oxygen, prostaglandins, sex hormones and smoking. Med Hypotheses 1979; 5: 447-452.
14. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis: Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J 1983; 50: 127-134.
15. Leafy T. Coronary spasm as a possible factor in producing sudden death. Am Heart J 1935; 10: 338-344.
16. Hellstrom H. R. Myocardial reperfusion injury: An assessment by the spasm of resistance vessel concept of ischemic heart disease. Med Hypotheses 1990; 33: 117-124.
17. Kuhn T. S. In: The Structure of Scientific Revolutions. Chicago: The University of Chicago Press, 1970: 1-210.
18. Hellstrom H. R. Plaque Rupture and Consequent Thromboses Probably do not Cause Acute Coronary Syndromes. In press.
19. Eng C., Cho S., Factor S. M., Sonnenblick E. H., Kirk E. S. Myocardial micronecrosis produced by microsphere embolization: Role of an α-adrenergic tonic influence on the coronary microcirculation. Circ Res 1984; 54: 74-82.
20. Karmazyn M., Horrobin D. F., Oka M. et al. Changes in coronary vascular resistance associated with prolonged hypoxia in isolated rat hearts: A possible role of prostaglandins. Life Sci 1979; 25: 1991-1999.
21. Gorman M. W., Sparks H. V., Jr. Progressive coronary vasoconstriction during relative ischemia in canine myocardium. Circ Res 1982; 51: 411-420.
22. Grayson J., Irvine M, Parratt J. R., Cunningham J. Vasospastic elements in myocardial infarction following coronary occlusion in the dog. Cardiovasc Res 1968; 2: 54-62.
23. Guyton R. A., McClenathan J. H., Michaelis L. L. Evolution of regional ischemia distal to a proximal coronary stenosis: Self-propagation of ischemia. Am J Cardiol 1977; 40: 381-392.
24. Gwirtz P. A., Overn S. P., Mass H. J., Jones C. E. α1-Adrenergic constriction limits coronary flow and cardiac function in running dogs. Am J Physiol 1986; 250: H1117-H1126.
25. Karmazyn M., Beamish R. E., Dhalla N. S. Involvement of calcium in coronary vasoconstriction due to prolonged hypoxia. Am Heart J 1984; 107: 293-297.
26. Hallenbeck J. M. Prevention of postischemic impairment of microvascular perfusion. Neurology 1977; 27: 3-10.
27. Heusch G., Deussen A., Thämer V. Cardiac sympathetic nerve activity and progressive vasoconstriction distal to coronary stenoses: Feed-back aggravation of myocardial ischemia. J Auton Nerv Syst 1985; 13: 311-326.
28. 1-Adrenergic blockade increases coronary blood flow during coronary hypoperfusion. Am J Physiol 1985; 249: H1070-H1077.
29. Sambuceti G., Marzilli M., Marraccini P. et al. Coronary vasoconstriction during myocardial ischemia induced by rises in metabolic demand in patients with coronary artery disease. Circulation 1997; 95: 2652-2659.
30. Seitelberger R., Guth B. D., Heusch G., Lee J.-D., Katayama K., Ross J., Jr. Intracoronary α-adrenergic receptor blockade attenuates ischemia in conscious dogs during exercise. Circ Res 1988; 62: 436-442.
31. Rubanyi G. M., Vanhoutte P. M. Hypoxia releases a vasoconstrictor substance from the canine vascular endothelium. J Physiol 1985; 364: 45-56.
32. Leaf A. Cell swelling: A factor in ischemic tissue injury. Circulation 1973; 48: 455-458.
33. Engler R. L., Schmid-Schönbein G. W., Pavelec R. S. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol 1983; 111: 98-111.
34. Topol E. J., Yadav J. S. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 2000; 101: 570-580.
35. Roe M. T., Ohman E. M., Maas A. C. P. et al. Shifting the open-artery hypothesis downstream: The quest for optimal reperfusion. J Am Coll Cardiol 2001; 37: 9-18.
36. Rochitte C. E., Lima J. A. C., Bluemke D. A. et al. Magnitude and time course of microvacular obstruction and tissue injury after acute myocardial infarction. Circulation 1998; 98: 1006-1014.
37. Piana R. N., Paik G. Y., Moscucci M. et al. Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. Circulation 1994; 89: 2514-2518.
38. Pemberton M., Anderson G. L., Barker J. H. Characterization of microvascular vasoconstriction following ischemia/reperfusion in skeletal muscle using videomicroscopy. Microsurgery 1996; 17: 9-16.
39. Pomerantz R. M., Kuntz R. E., Diver D. J., Safian R. D., Baim D. S. Intracoronary verapamil for the treatment of distal microvascular coronary artery spasm following PTCA. Catheter Cardiovasc Diagn 1991; 24: 283-285.
40. Wilson R. F., Laxson D. D., Lessser J. R., White C. W. Intense microvascular constriction after angioplasty of acute thrombotic coronary arterial lesions. Lancet 1989; 1: 807-811.
41. Núñez B. D., Keelan E. T., Higano S. T., Lerman A., Garratt K. N., Holmes D. R., Jr. Coronary hemodynamics before and after rotational atherectomy with adjunctive balloon angioplasty. Catheter Cardiovasc Diagn 1996;(suppl. 3): 40-49.
42. Ito H., Tomooka T., Sakai N. et al. Lack of myocardial perfusion immediately after successful thrombolysis: A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992; 85: 1699-1705.
43. Abbo K. M., Dooris M., Glazier S. et al. Features and outcome of no-reflow after percutaneous coronry intervention. Am J Cardiol 1995; 75: 778-782.
44. Ishihara M., Sato H., Tateishi H. et al. Attenuation of the no-reflow phenomenon after coronary angioplasty for acute myocardial infarction with intracoronary papaverine. Am Heart J 1996; 132: 959-963.
45. Uren N. G., Crake T., Lefroy D. C., de Silva R., Davies G. J., Maseri A. Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction. N Engl J Med 1994; 331: 222-227.
46. Boden W. E. Anti-ischaemic therapy during the follow-up phase of acute coronary syndromes: Is there a role for calcium channel blockers?. Drugs 1996; 52: 20-30.
47. Ito H., Taniyama Y., Iwakura K. et al. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol 1999; 33: 654-660.
48. Mahaffey K. W., Puma J. A., Barbagelata A. et al. Adensine as an adjunct to thrombolytic therapy for acute myocardial infaraction. J Am Coll Cardiol 1999; 34: 1711-1720.
49. Olafsson B., Forman M. B., Puett D. W. et al. Reduction of perfusion injury in the canine preparation by intracoronary adenosine: Importance of the endothelium and the no-reflow phenomenon. Circulation 1987; 76: 1135-1145.
50. Yang B., Graham L., Dikalov S. et al. Overexpression of cytochrome P450 CYP2J2 protects against hypoxiareoxygenation injury in cultured bovine aortic endothelial cells. Mol Pharmacol 2001; 60: 310-320.
51. Mangano D. T. Effects of acadesine on myocardial infarction, stroke, and death following surgery. JAMA 1996; 277: 325-332.
52. Gregorini L., Marco J., Palombo C. et al. Postischemic left ventricular dysfunction is abolished by α-adreneragic blocking agents. J Am Coll Cardiol 1998; 31: 992-1001.
53. Krug A., de Rochemont W. d. M., Korb G. Blood supply of the myocardium after temporary coronary occlusion. Circ Res 1966; 19: 57-62.
54. Kloner R. A., Ganote C. E., Jennings R. B. The 'no-reflow' phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974; 54: 1496-1508.
55. Gregorini L., Marco J., Kozáková M. et al. α-Adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction. Circulation 1999; 99: 482-490.
56. Gibson C. M., Cannon C. P., Daley W. L. et al. TIMI frame count: A quantitative method of assessing coronary artery flow. Circulation 1996; 93: 879-888.
57. Gibson C. M., Murphy S. A., Rizzo M. J. et al. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Circulation 1999; 99: 1945-1950.
58. Gregg D. E. Relationship between coronary flow and metabolic changes. Cardiology 1971; 56: 291-301.
59. Gibson C. M., Goel M., Murphy S. A. et al. Global impairment of coronary blood flow in the setting of acute coronary syndromes (a RESTORE substudy). Am J Cardiol 2000; 86: 1375-1377.
60. Ito H., Iwakura K. Assessing the relation between coronary reflow and myocardial reflow. Am J Cardiol 1998; 81: 8G-12G.
61. Iwakura K., Ito H., Takiuchi S. et al. Alteration in the coronary blood flow velocity pattern in patients with no reflow and reperfused acute myocardial infarction. Circulation 1996; 94: 1269-1275.
62. Wakatsuki T., Oki T., Sakabe K. et al. Coronary flow velocity immediately after reperfusion reflects myocardial microcirculation in canine models of acute myocardial infarction. Angiology 1999; 50: 919-928.
63. Akasaka T., Yoshida K., Kawamoto T. et al. Relation of phasic coronary flow velocity characteristics with TIMI perfusion grade and myocardial recovery after primary percutaneous transluminal coronary angioplasty and rescue stenting. Circulation 2000; 101: 2361-2367.
64. Takeuchi M., Kuroiwa A. Alteration of coronary flow velocity during spontaneous angina in a patient with microvascular angina. Catheter Cardiovasc Intervent 2000; 50: 63-67.
65. Mohri M., Koyanagi M., Egashira K. et al. Angina pectoris caused by coronary microvascular spasm. Lancet 1998; 351: 1165-1169.
66. Yamagishi H., Itagane H., Hato K. et al. A case of rest angina due to microvascular spasm. Jpn Circ J 1997; 61: 87-89.
67. Murakami H., Urabe K., Nishimura M. Inappropriate microvascular constriction produced transient ST-segment elevation in patients with Syndrome X. J Am Coll Cardiol 1998; 32: 1287-1294.
68. Sekiya M., Okayama H., Suzuki M. et al. Acetylcholine-induced myocardial ischemia without epicardial coronary artery spasm: A possible vasospasm of small coronary arteries - A case report. Angiology 1993; 44: 811-815.
69. Heye N., Cervós-Navarro J. Microthromboemboli in acute infarcts: Analysis of 40 autopsy cases. Stroke 1996; 27: 431-434.
70. Koch K.-C., vom Dahl J., Kleinhans E. et al. Influence of a platelet GP IIb/IIIa receptor antagonist on myocardial hypoperfusion during rotational atherectomy as assessed by myocardial Tc-99m sestamibi scintigraphy. J Am Coll Cardiol 1999; 33: 998-1004.
71. Klootwijk P., Meij S., Melkert R., Lenderink T., Simoons M. L. Reduction of recurrent ischemia with abciximab during continuous ECG-ischemia monitoring in patients with unstable angina refractory to standard treatment (CAPTURE). Circulation 1998; 98: 1358-1364.
72. de Lemos J. A., Antman E. M., Gibson C. M. et al. Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction: Observations from the TIMI 14 Trial. Circulation 2000; 101: 239-243.
73. Chew D. P., Moliterno D. J. A critical appraisal of platelet glycoprotein IIb/IIIa inhibition. J Am Coll Cardiol 2000; 36: 2028-2035.
74. Beebe H. G. Intermittent claudication: Effective medical management of a common circulatory problem. Am J Cardiol 2001; 87: 14D-18D.
75. Loscalzo J., Welch G. Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis 1995; 38: 87-104.
76. 2 biosynthesis. J Biol Chem 1989; 264: 141-150.
77. Schini V. B., Hendrickson H., Heublein D. M., Burnett J. C., Jr., Vanhoutte P. M. Thrombin enhances the release of endothelin from cultured porcine aortic endothelial cells. Eur J Pharmacol 1989; 165: 333-334.
78. Lum H., Andersen T. T., Fenton II J. W., Malik A. B. Thrombin receptor activation peptide induces pulmonary vasoconstriction. Am J Physiol 1994; 266: C448-C454.
79. Darius H., Yanagisawa A., Brezinski M. E., Hock C. E., Lefer A. M. Beneficial effects of tissue-type plasminogen activator in acute myocardial ischemia in cats. J Am Coll Cardiol 1986; 8: 125-131.
80. Roberts W. C., Buja L. M. The frequency and significance of coronary arterial thrombi and other observations in fatal acute myocardial infarction: A study of 107 necropsy patients. Am J Med 1972; 52: 425-443.
81. Friedman H. Z., Elliot M. A., Gottlieb G. J., O'Neill W. W. Mechanical rotational atherctomy: The effects of microparticle embolization on myocardial blood flow and function. J Interven Cardiol 1989; 2: 77-83.
82. Ricciardi M. J., Wu E., Davidson C. J. et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation 2001; 103: 2780-2783.
83. Barrabes J. A., Garcia-Dorado D., Soriano B. et al. Dynamic intracoronary thrombosis does not cause significant downstream platelet embolization. Cardiovasc Res 2000; 47: 265-273.
84. Wakatsuki T., Nakamura M., Tsunoda T. et al. Coronary flow velocity immediately after primary coronary stenting as a predictor of ventricular wall motion recovery in acute myocardial infarction. J Am Coll Cardiol 2000; 35: 1835-1841.
85. Friedman M., Thoresen C. E., Gill J. J. et al. Feasibility of altering type A behavior pattern after myocardial infarction. Recurrent Coronary Prevention Project Study: Methods, baseline results and preliminary findings. Circulation 1982; 66: 83-92.
86. Vogel R. A., Corretti M. C., Plotnick G. D. The postprandial effect of components of the Mediterranean diet on endothelial function. J Am Coll Cardiol 2000; 36: 1455-1460.
87. L'Abbate A., Simonetti I., Carpeggiani C., Michelassi C. Coronary dynamics and mental arithmetic stress in humans. Circulation 1991; 83(Suppl. II): II-94-II-99.
88. Mittleman M. A., Maclure M., Sherwood J. B. et al. Triggering of acute myocardial infarction onset by episodes of anger. Circulation 1995; 92: 1720-1725.
89. Goldberg A. D., Becker L. C., Bonsall R. et al. Ischemia, hemodynamic, and neurohormonal responses to mental and exercise stress: Experience from the Psychophysiological Investigations of Myocardial Ischemia Study (PIMI). Circulation 1996; 94: 2402-2409.
90. Rajkumar C., Simpson H., Jennings G. L., Dart A. M. Postprandial silent ischaemia following a fatty meal in patients with recently diagnosed coronary artery disease. J Hum Hypertens 2000; 14: 391-394.
91. Albert C. M., Mittleman M. A., Chae C. U., Lee I.-M., Hennekens C. H., Manson J. E. Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med 2000; 343: 1355-1361.
92. Williams M. J. A., Sutherland W. H. F., McCormick M. P., de Jong S. A., Walker R. J., Wilkins G. T. Impaired endothelial function following a meal rich in used cooking fat. J Am Coll Cardiol 1999; 33: 1050-1055.
93. Haller C. A., Benowitz N. L. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med 2000; 343: 1833-1838.
94. Kral B. G., Becker L. C., Blumenthal R. S. et al. Exaggerated reactivity to mental stress is associated with exercise-induced myocardial ischemia in an asymptomatic high-risk population. Circulation 1997; 96: 4246-4253.
95. Giubbini R., Galli M., Campini R., Bosimini E., Bencivelli W., Tavazzi L. Effects of mental stress on myocardial perfusion in patients with ischemic heart disease. Circulation 1991; 83(Suppl. II): II-100-II-107.
96. Deanfield J. E., Shea M., Kensett M. et al. Silent myocardial ischaemia due to mental stress. Lancet 1984; 2: 1001-1005
97. Specchia G., Falcone C., Traversi E. et al. Mental stress as a provocative test in patients with various clinical syndromes of coronary heart disease. Circulation 1991; 83(Suppl. II): II-108-II-114.
98. Krantz D. S., Helmers K. F., Bairey C. N., Nebel L. E., Hedges S. M., Rozanski A. Cardiovascular reactivity and mental stress-induced myocardial ischemia in patients with coronary artery disease. Psychosom Med 1991; 53: 1-12.
99. Natelson B. H., Tapp W. N., Drastal S., Suarez R., Ottenweller J. E. Hamsters with coronary spasm are at increased risk from stress. Psychosom Med 1991; 53: 322-331.
100. Noll G., Wenzel R. R., Schneider M. et al. Increased activation of sympathetic nervous system and endothelin by mental stress in normotensive offspring of hypertensive parents. Circulation 1996; 93: 866-869.
101. Piatti P., Fragasso G., Monti L. D. et al. Endothelial and metabolic characteristics of patients with angina and angiographically normal coronary arteries: Comparison with subjects with insulin resistance syndrome and normal controls. J Am Coll Cardiol 1999; 34: 1452-1460.
102. Reis S. E., Holubkov R., Lee J. S. et al. Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease: Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol 1999; 33: 1469-1475.
103. Lekakis J. P., Papamichael C. M., Vemmos C. N., Voutsas A. A., Stamatelopoulos S. F., Moulopoulos S. D. Peripheral vascular endothelial dysfunction in patients with angina pectoris and normal coronary arteriograms. J Am Coll Cardiol 1998; 31: 541-546.
104. Legrand V., Hodgson J. M., Bates E. R. et al. Abnormal coronary flow reserve and abnormal radionuclide exercise test results in patients with normal coronary angiograms. J Am Coll Cardiol 1985; 6: 1245-1253.
105. Koglin J., von Scheidt W. Isolated defect of adenosine-mediated coronary vasodilation: Functional evidence for a new microangiopathic entity. J Am Coll Cardiol 1997; 30: 103-107.
106. Egashira K., Inou T., Hirooka Y., Yamada A., Urabe Y., Takeshita A. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med 1993; 328: 1659-1664.
107. Motz W., Vogt M., Rabenau O., Scheler S., Lückhoff A., Strauer B. E. Evidence of endothelial dysfunction in coronary resistance vessels in patients with angina pectoris and normal coronary angiograms. Am J Cardiol 1991; 68: 996-1003.
108. Sax F. L., Cannon R. O. I., Hanson C., Epstein S. E. Impaired forearm vasodilator reserve in patients with microvascular angina: Evidence of a generalized disorder of vascular function. N Engl J Med 1987; 317: 1366-1370.
109. Serota H., Kern M. J., Deligonul U., Aguirre F., Caralis D. G. Ergonovine-induced myocardial ischemia without epicardial coronary vasospasm: Evidence for ischemia produced by small-vessel vasoconstriction. Am Heart J 1991; 121: 1807-1809.
110. Kaski J. C., Maseri A., Vejar M., Crea F., Hackett D., Halson P. Spontaneous coronary artery spasm in variant angina is caused by a local hyperreactivity to a generalized constrictor stimulus. J Am Coll Cardiol 1989; 14: 1456-1463.
111. Kleiman N. S., Lehane D. E., Geyer C. E., Jr., Pratt C. M., Young J. B. Prinzmetal's angina during 5-fluorouracil chemotherapy. Am J Med 1987; 82: 566-568.
112. Maseri A., Severi S., de Nes M. et al. 'Variant' angina: One aspect of a continuous spectrum of vasospastic myocardial ischemia: Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients. Am J Cardiol 1978; 42: 1019-1035.
113. Ornish D., Scherwitz L. W., Doody R. S. et al. Effects of stress management training and dietary changes in treating ischemic heart disease. JAMA 1983; 249: 54-59.
114. Ornish D., Brown S. E., Scherwitz L. W. et al. Can lifestyle changes reverse coronary heart disease? The lifestyle heart trial. Lancet 1990; 336: 129-133.
115. de Divitiis M., Rubba P., Di Somma S. et al. Effects of short-term reduction in serum cholesterol with simvastatin in patients with stable angina pectoris and mild to moderate hypercholesterolemia. Am J Cardiol 1996; 78: 763-768.
116. O'Driscoll G., Green D., Taylor R. R. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 1997; 95: 1126-1131.
117. Pupita G., Maseri A., Kaski J. C. et al. Myocardial ischemia caused by distal coronary-artery constriction in stable angina pectoris. N Engl J Med 1990; 323: 514-520.
118. Chierchia S., Brunelli C., Simonetti I., Lazzari M., Maseri A. Sequence of events in angina at rest: Primary reduction in coronary flow. Circulation 1980; 61: 759-768.
119. Marzilli M., Sambuceti G., Fedele S., L'Abbate A. Coronary microcirculatory vasoconstriction during ischemia in patients with unstable angina. J Am Coll Cardiol 2000; 35: 327-337.
120. Przybojewski J. A. Myocardial infarction complicating dilated (congestive) cardiomyopathy in an industrial nitroglycerin worker: A case report. S Afr Med J 1986; 69: 381-384.
121. Azevedo E. R., Schofield A. M., Kelly S., Parker J. D. Nitroglycerin withdrawal increases endothelium-dependent vasomotor response to acetylcholine. J Am Coll Cardiol 2001; 37: 505-509.
122. Przybojewski J. A., Hyns M. H. Acute coronary vasospasm secondary to industrial nitroglycerin withdrawal; a case presentation and review. S Afr Med J 1983; 63: 158-165.
123. Alderman M. H., Madhavan S., Ooi W. L., Cohen H., Sealey J. E., Laragh J. H. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 1991; 324: 1098-1104.
124. Mangano D. T., Browner W. S., Hollenberg M., London M. J., Tubau J. F., Tateo I. M. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. N Engl J Med 1990; 323: 1781-1788.
125. Théroux P. A pathophysiological basis for the clinical classification and management of unstable angina. Circulation 1987; 75(Suppl. V): V-103-V-109.
126. Braunwald E., Antman E. M., Califf R. M. et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. J Am Coll Cardiol 2000; 36: 970-1062.
127. Hosokawa R., Nohara R., Linxue L. et al. Effect of long-term cholesterol-lowering treatment with HMG-CoA reductase inhibitor (simvastatin) on myocardial perfusion evaluated by thallium-201 single photon emission computed tomography. Jpn Circ J 2000; 64: 177-182.
128. Wu K. C., Zerhouni E. A., Judd R. M. et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998; 97: 765-772.
129. Ito H., Okamura A., Iwakura K. et al. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation 1999; 93: 1993-1999.
130. Antman E. M., Fox K. M. Guidelines for the diagnosis and management of unstable angina and non-Q-wave myocardial infarction: Proposed revisions. Am Heart J 2000; 139: 461-475.
131. Morishima I., Sone T., Mokuno S. et al. Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of acute myocardial infarction with percutaneous transluminal coronary angioplasty. Am Heart J 1995; 130: 239-243.
132. Stone G. W., Cox D., Garcia E. et al. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction; analysis from the Primary Angioplasty in Myocardial Infarction Trials. Circulation 2001; 104: 636-641.
133. Heusch G. α-Adrenergic mechanisms in myocardial ischemia. Circulation 1990; 81: 1-13.
134. Buffington C. W., Feigl E. O. Adrenergic coronary vasoconstriction in the presence of coronary stenosis in the dog. Circ Res 1981; 48: 416-423.
135. Khalil M. E., Basher A. W., Brown E. J., Jr., Alhaddad I. A. A remarkable medical story: Benefits of angiotensin-converting enzyme inhibitors in cardiac patients. J Am Coll Cardiol 2001; 37: 1757-1764.
136. Zanzinger J., Czachurski J., Seller H. Inhibition of sympathetic vasoconstriction is a major principle of vasodilation by nitric oxide in vivo. Circ Res 1994; 75: 1073-1077.
137. Saino A., Pomidossi G., Perondi R., Morganti A., Turolo L., Mancia G. Modulation of sympathetic coronary vasoconstriction by cardiac renin-angiotensin system in human coronary heart disease. Circulation 2000; 101: 2277-2283.
138. Remme W. J. The sympathetic nervous system and ischaemic heart disease. Eur Heart J 1998; 19(suppl. F): F62-F71.
139. Liu Y. H., Yang X. P., Sharov V. G., Sigmon D. H., Sabbath H. N., Carretero O. A. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats. Hypertension 1996; 27: 7-13.
140. Piana R. N., Wang S. Y., Friedman M., Sellke F. W. Angiotensin-convening enzyme inhibition preserves endothelium-dependent coronary microvascular responses during short-term ischemia-reperfusion. Circulation 1996; 93: 544-551.
141. Kennon S., Barakat K., Hitman G. A. et al. Angiotensinconverting enzyme inhibition is associated with reduced troponin release in non-ST-elevation acute coronary syndromes. J Am Coll Cardiol 2001; 38: 724-728.
142. Spinler S. A., Hilleman D. E., Cheng J. W. et al. New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines. Ann Pharmacother 2001; 35: 589-617.
143. Ellis S. G., Brener S. J., Lincoff A. M. et al. β-Blockers before percutaneous coronary intervention do not attenuate postprocedural creatine kinase isoenzyme rise. Circulation 2001; 104: 2685-2688.
144. + exchanger: A potential therapeutic target for the prevention of myocardial ischaemic and reperfusion injury and attenuation of postinfarction heart failure. Drugs 2001; 61: 375-389.
145. + exchange inhibitor (SM-20550) protects from microvascular deterioration and myocardial injury after reperfusion. Eur J Pharmacol 1999; 374: 355-366.
146. Théroux P., Chairman B. R., Danchin N. et al. Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Circulation 2000; 102: 3032-3038.
147. + exchanger produces vasoconstriction of renal resistance vessels. Am J Hypertens 1998; 11: 1214-1221.
148. Hattori R., Otani H., Moriguchi Y. et al. NHE and ICAM-1 expression in hypoxic/reoxygenated coronary microvascular endothelial cells. Am J Physiol 2001; 280: H2796-H2803.
149. Gumina R. J., Moore J., Schelling P., Beier N., Gross G. J. Na(+)/H(+) exchange inhibition prevents endothelial dysfunction after I/R injury. Am J Physiol 2001; 281: H1260-H1266.
150. Avkiran M., Yokoyama H. Adenosine A(1) receptor stimulation inhibits α(1)-adrenergic activation of the cardiac sarcolemmal Na(+)/H(+) exchanger. Br J Pharmacol 2000; 131: 659-662.
151. 2+ in coronary smooth muscle: Role of Na(+)-H(+) exchange. Biochem J 1995; 310: 1013-1020.
152. Hoque N., Cook M. A., Karmazyn M. Inhibition of α(1)-adrenergic-mediated responses in rat ventricular myocytes by adenosine A(1) receptor activation: Role of the K(ATP) channel. J Pharmacol Exp Ther 2000; 294: 770-777.
153. Barton R. N. The neuroendocrinology of physical injury. Baillieres Clin Endocrinol Metab 1987; 1: 355-374.
154. Pottmeyer E., Vassar M. J., Holcroft J. W. Coagulation, inflammation, and responses to injury. Crit Care Clin 1986; 2: 683-703.
155. Lincoff A. M., Califf R. M., Topol E. J. Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease. J Am Coll Cardiol 2000; 35: 1103-1115.
156. Green P. G., Luo J., Heller P. H., Levine J. D. Further substantiation of a significant role for the sympathetic nervous system in inflammation. Neuroscience 1993; 55: 1037-1043.
157. Kidd B. L., Cruwys S., Mapp P. I., Blake D. R. Role of the sympathetic nervous system in chronic joint pain and inflammation. Ann Rheum Dis 1992; 51: 1188-1191.
158. Waters D. D. H. What is the role of intensive cholesterol lowering in the treatment of acute coronary syndromes?. Am J Cardiol 2001; 88(Suppl.): 7J-16J.
159. O'Driscoll G., Green D., Maiorana A., Stanton K., Colreavy F., Taylor R. Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes. J Am Coll Cardiol 1999; 33: 1506-1511.
160. Ryan T. J., Antman E. M., Brooks N. H. et al. 1999 Update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 1999; 100: 1016-1030.
161. Dupuis J., Tardif J.-C., Cernacek P., Théroux P. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes: The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial. Circulation 1999; 99: 3227-3233.
162. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
163. Wilson P. W. F., D'Agostino R. B., Levy D., Belanger A. M., Silbershatz H., Kannel W. B. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-1847.
164. Smith S. C., Jr., Blair S. N., Bonow R. O. et al. AHA/ACC Scientific Statement: AHA/ACC Guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 2001; 104: 1577-1579.
165. Lenfant C. A new challenge for America: The National Cholesterol Education Program. Circulation 1986; 73: 855-856.
166. Lenfant C. Task force on behavioral research in cardiovascular, lung, and blood health and disease. Circulation 1998; 98: 281-286.
167. Hellstrom H. R. Cholesterol, an important but relatively overemphasized risk factor for ischemic heart disease. Med Hypotheses 2001; 57: 593-601.
168. Cooke J. P., Tsao P. S. Go with the flow. Circulation 2001; 103: 2773-2775.
169. Petersen C. L., Hansen A., Frandsen E. et al. Endothelin release and enhanced regional myocardial ischemia induced by cold-air inhalation in patients with stable angina. Am Heart J 1994; 128: 511-516.
170. Kay P., Kittelson J., Stewart R. A. Relation between duration and intensity of first exercise and 'warm up' in ischaemic heart diseae. Heart 2000; 83: 17-21.